HeraMED Ltd. engages in the development and production of pregnancy monitoring solutions for home and professional use. Its product HeraBEAT, is a medical grade, foetal heart rate monitors mainly for home use. The company was founded by David Groberman and Tal Slonim on October 5, 2011 and is headquartered in Sydney, Australia.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company